Off-label uses of drug-eluting stents is common
Device Regulation Alert: Safety, Compliance and Reimbursement News, May 14, 2007
About half of drug-eluting stents used between 2004 and 2005 were used for off-label purposes, according to two studies in last week's Journal of the American Medical Association (JAMA).
However, the two studies came to different conclusions about whether untested uses of the stents resulted in danger for patients. One study found that compared with on-label use, off-label use of drug-eluting stents is associated with a higher rate of adverse outcomes, such as stent thrombosis.
In the other study, researchers found that adverse events were relatively uncommon with both on- and off-label uses.
An editorial in JAMA discussed the two studies and stressed the importance of systematic data collection for improved device safety.
Go to the JAMA Web site read more.
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Big Pharma Performance Before, During and Beyond the Global Recession
This report assesses the performance of the leading 15 pharmaceutical companies up to, during and beyond the recent global...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- Capturing all necessary codes for IUD insertion and removal can be challenging
- QA:Coding multiple initial infusions
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Q&A tackles coding questions about injections and infusions
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- Case Management Monthly, June 2012
- Searched